- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
SYUT Market Currents
more »
-
January 20 Synutra (SYUT +2.7%), which was crushed last week after the death of a child who consumed its infant formula triggered an investigation, is rebounding a bit after stating government tests conducted on formula purchased by the child's family found it to be compliant with regulations. Synutra is also reiterating its December quarter sales forecast of $90M-$93M, though that range is below a $93.8M consensus.
Comment![Healthcare, On the Move]
SYUT in Focus
more »
SYUT Related Articles
more »
SYUT News
more »
-
at MarketWatch.com (Jan 13, 2012)
-
at MarketWatch.com (Jan 12, 2012)
-
at MarketWatch.com (Aug 16, 2010)
-
at MarketWatch.com (Aug 9, 2010)
-
at MarketWatch.com (Jun 25, 2010)
SYUT Press Releases and Filings
more »
-
PR Newswire (Jan 27, 2012)
-
PR Newswire (Jan 20, 2012)
-
PR Newswire (Jan 13, 2012)
-
PR Newswire (Jan 12, 2012)
-
PR Newswire (Dec 19, 2011)
SYUT Latest Transcript
more »
Currently, there are no transcripts for SYUT.
SYUT Cramer
more »
Currently, there are no Cramer articles on SYUT.
SYUT Instablog posts
more »
SYUT vs. ETF Alternatives
Company Description
Currently, there's no company description for SYUT.